New changes will come to market in Q2 2020
Philips Zenition Mobile C-Arm Platform. Image from Philips Healthcare
Philips Healthcare has announced two major innovations to its X-ray system, the Zenition mobile C-arm platform, including a new Table Side User Interface and an extension integrating intravascular ultrasound (IVUS).
With the change to the Table Side User Interface, clinicians will be able to operate the C-arm inside a sterile field. It also streamlines communication with the operator and potentially makes controlling the system more intuitive. While standing at the table, the clinician will be able to use a tablet-like user interface with a 12.1-inch display to control the system. Providers can also choose to position the interface at a variety of angles or use it as a viewing monitor on the patient table, according to company information.
Additionally, the Zenition has been extended to IVUS for peripheral vascular procedures, potentially streamlining activity and workflow in the operating room. As a catheter-based imaging technology, IVUS lets physicians see blood vessels from the inside-out. This can improve treatment for peripheral vascular and coronary patients.
Information gathered from analyzing vascular morphology in blood vessels and providing vessel cross-sectional imaging, IVUS can contribute to correctly sizing stents and confirming whether treatment is complete, according to the release. Providers will now be able view and control IVUS imaging output, including measurement and replay features, from the Zenition.
The Zenition system is CE marked and already available in the U.S. market, and the innovations will be available in the second quarter of 2020. Customers will be able to purchase the Table Side User Interface for use on the Zenition 70, and the IVUS integration will be available across the entire Zenition portfolio.
Can AI Facilitate Improved Dual-Energy X-Ray Screening for Patients at High Risk of Osteoporosis?
June 28th 2024Out of 315 patients identified by artificial intelligence (AI) as being at high risk for osteoporosis, subsequent screening with dual-energy X-ray absorptiometry (DXA) in a randomized controlled trial revealed new-onset osteoporosis in 237 patients.
FDA Clears Mobile C-Arm Device Designed for Complex Vascular Procedures
June 17th 2024Offering a combination of intuitive user-friendly controls and enhanced imaging, the Zenition 90 Motorized C-arm reportedly facilitates workflow efficiencies and bolsters visualization for complex vascular procedures, cardiac interventions, and other clinical procedures.
Qure.ai to Debut Multimodality AI Platform for Lung Cancer Imaging at ASCO 2024
May 29th 2024In addition to detecting missed lung nodules on X-rays, the AI-powered Qure.ai lung cancer continuum platform reportedly automates lung nodule measurement on CT scans and facilitates multimodality reporting.